Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Lilly research into antiobesity proteins continues

Dec. 2, 1996

Dual-action PDE IV/TNF-alpha inhibitors reported by Janssen

Dec. 2, 1996

Novel porphycene compounds synthesized at Cytopharm

Dec. 2, 1996

New serotoninergic drugs from E. Merck

Nov. 29, 1996

Novel nonmacrolide antitumor agent discovered by Mitsubishi

Nov. 29, 1996

Takeda discloses natural ET receptor antagonist

Nov. 29, 1996

Takeda describes antiprotozoal agents

Nov. 29, 1996

New bombesin analogues from Biomeasure

Nov. 29, 1996

Merck & Co. describes new compounds for dopamine-related disorders

Nov. 29, 1996

NEP inhibitors claimed by Santen

Nov. 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...